Safety and immunogenicity of a glycoprotein E gene-deleted bovine herpesvirus 1 strain as a candidate vaccine strain

• Main Authors: Marcelo Weiss, Deniz Anziliero, Mathias Martins, Rudi Weiblen, Eduardo Furtado Flores
• Format: Article
• Language: English
• Published: Colégio Brasileiro de Patologia Animal (CBPA)
• Series: Pesquisa Veterinária Brasileira
• Subjects: BoHV-1; bovinos; vacinas marcadas; vacinas diferenciais
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2016001101067&lng=en&tlng=en
• ISSN: 1678-5150

ABSTRACT: A glycoprotein E-deleted Brazilian bovine herpesvirus 1 (BoHV-1gEΔ) was tested regarding to safety and immunogenicity. Intramuscular inoculation of young calves with a high virus dose did not result in clinical signs or virus shedding during acute infection or after dexamethasone administration. Calves vaccinated once IM (group I) or subcutaneously (group II) with live BoHV-1gEΔ or twice with inactivated virus plus aluminum hydroxide (group IV) or Montanide™ (group V) developed VN titers of 2 to 8 (GMT:2); 2 to 4 (GMT:1.65); 2 to 16 (GMT:2.45) and 2 to 128 (GMT:3.9), respectively. All BoHV-1gEΔ vaccinated calves remained negative in an anti-gE ELISA. Lastly, six young calves vaccinated with live BoHV-1gEΔ and subsequently challenged with a virulent BoHV-1 strain shed less virus and developed only mild and transient nasal signs comparing to unvaccinated calves. Thus, the recombinant BoHV-1gEΔ is safe and immunogenic for calves and allows for serological differentiation by a gE-ELISA test.